A carregar...
Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care
In diffuse large B-cell lymphoma (DLBCL), predictive modeling may contribute to targeted drug development by enrichment of the study populations enrolled in clinical trials of DLBCL investigational drugs to include patients with lower likelihood of responding to standard of care. In clinical practic...
Na minha lista:
| Publicado no: | Cancer Inform |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6421613/ https://ncbi.nlm.nih.gov/pubmed/30906191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1176935119835538 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|